Molecular and phenotypic detection technologies

Hospitals are increasingly encountering unpredictable resistance patterns clinically while being faced with the need to minimise broad-spectrum antibiotic use to prevent and reduce antimicrobial resistance. For patients with sepsis, time to effective and optimised therapy is critical. Accelerate Diagnostics has created breakthrough diagnostic solutions by developing technologies that address the needs of clinicians and the laboratory.

The company’s fully automated ID/AST system Accelerate Pheno and direct from positive blood culture kit Accelerate PhenoTest BC utilise proprietary molecular and phenotypic detection technologies that have been demonstrated to reduce substantially the time to definitive, actionable antimicrobial susceptibility and MIC results by one to two days, compared with conventional methods.

www.acceleratediagnostics.com

 

Other news

Upcoming Events

Pathology Horizons 2018 Conference

Lough Erne Resort, Co. Fermanagh, Northern Ireland
September 13-15

Microbe 2018

Hilton Hotel, Sheffield
21-23 September 2018

World Congress of the International Federation of Biomedical Laboratory Science (IFBLS)

Palazza dei Congressi of Firenze
22-26 September 2018

Infection Prevention 2018

Scottish Events Campus, Glasgow
30 September - 2 October 2018

Going Overboard with Microbiology - Women and Children First

Merseyside Maritime Museum, Albert Dock, Liverpool
19 October 2018

Latest Issue

Pathology In Practice

Pathology In Practice

Aug 2018

Cryotomy in a Mohs service: the Welsh experience

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.